litlas
ログインアカウント作成

Howard S. Höchster

1985–2025 年に発表

93
論文数
20,520
被引用数
68
h 指数
90
i10 指数

被引用数

Howard S. Höchster の年別被引用数1986 年: 被引用 1 件1988 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 8 件1993 年: 被引用 11 件1994 年: 被引用 17 件1995 年: 被引用 14 件1996 年: 被引用 20 件1997 年: 被引用 15 件1998 年: 被引用 19 件1999 年: 被引用 18 件2000 年: 被引用 25 件2001 年: 被引用 25 件2002 年: 被引用 36 件2003 年: 被引用 25 件2004 年: 被引用 32 件2005 年: 被引用 48 件2006 年: 被引用 47 件2007 年: 被引用 69 件2008 年: 被引用 71 件2009 年: 被引用 93 件2010 年: 被引用 105 件2011 年: 被引用 79 件2012 年: 被引用 71 件2013 年: 被引用 75 件2014 年: 被引用 82 件2015 年: 被引用 115 件2016 年: 被引用 120 件2017 年: 被引用 176 件2018 年: 被引用 162 件2019 年: 被引用 702 件2020 年: 被引用 751 件2021 年: 被引用 845 件2022 年: 被引用 682 件2023 年: 被引用 483 件2024 年: 被引用 770 件2025 年: 被引用 345 件2026 年: 被引用 10 件1987 年は被引用が無いため表示していません1989〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,233 件、この内訳の 24.5%中国: 引用元論文 1,212 件、この内訳の 13.3%イタリア: 引用元論文 634 件、この内訳の 6.9%ドイツ: 引用元論文 468 件、この内訳の 5.1%イギリス: 引用元論文 446 件、この内訳の 4.9%日本: 引用元論文 402 件、この内訳の 4.4%フランス: 引用元論文 388 件、この内訳の 4.3%スペイン: 引用元論文 337 件、この内訳の 3.7%オランダ: 引用元論文 271 件、この内訳の 3%カナダ: 引用元論文 256 件、この内訳の 2.8%オーストラリア: 引用元論文 220 件、この内訳の 2.4%ベルギー: 引用元論文 180 件、この内訳の 2%
0%24.5%その他 22.7%

機関

分野

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology15%
  • Immunology and Microbiology3.2%
  • Materials Science1.3%
  • Engineering0.6%
  • Nursing0.5%
  • その他1.5%

トピック

  • Colorectal Cancer Treatments and Studies7.6%
  • Pancreatic and Hepatic Oncology Research4.8%
  • Cancer Immunotherapy and Biomarkers4.1%
  • Colorectal Cancer Surgical Treatments4%
  • Cancer Genomics and Diagnostics3.7%
  • Genetic factors in colorectal cancer3.1%
  • その他72.7%

共著者

全論文

検索で開く
  1. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    著者: Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Éveline Boucher, Marc Peeters, Ben Tran, Heinz‐Josef Lenz, Alberto Zaniboni, Howard S. Höchster, James M. Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu - New England Journal of Medicine 2015 被引用: 1,431

  2. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

    著者: Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero, Elena Élez, Takayuki Yoshino, Alberto Sobrero, James C. Yao, Pilar García‐Alfonso, Judit Kocsis, Antonio Cubillo Gracián, Andrea Sartore‐Bianchi, Taroh Satoh, Violaine Randrian, Jiří Tomášek, Geoff Chong, Andrew Scott Paulson, Toshiki Masuishi, Jeremy Jones, Tibor Csőszi, Chiara Cremolini, François Ghiringhelli, Ardaman Shergill, Howard S. Höchster, John C. Krauss, Ali Bassam, Michel Ducreux, Anneli Elme, Laurence Faugeras, Stefan Kasper, Eric Van Cutsem, Dirk Arnold, Shivani Nanda, Zhao Yang, William R. Schelman, Marek Kania, Josep Tabernero, Cathy Eng - The Lancet 2023 被引用: 323

  3. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

    著者: Michael S. Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P. Hack, Jessica Spahn, Bo Liu, Heba Abdullah, Yulei Wang, Aiwu Ruth He, Kyung-Hun Lee, Y-J. Bang, Johanna C. Bendell, Yee Chao, J-S Chen, Hyun Cheol Chung, S. Lindsey Davis, Atul Dev, Edward Gane, Ben George, Aiwu Ruth He, Howard S. Höchster, C-H Hsu, Masafumi Ikeda, Jes Chauviere Lee, M. Lee, Amit Mahipal, Gulam A. Manji, Manabu Morimoto, Kazushi Numata, Michael J. Pishvaian, Shukui Qin, David P. Ryan, B-Y Ryoo, Naoki Sasahira, Stacey Stein, John H. Strickler, N. C. Tebbutt - The Lancet Oncology 2020 被引用: 567

  4. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

    著者: Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke - JAMA 2017 被引用: 893

  5. Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

    著者: Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy, Jeremy Kortmansky, Jaykumar Thumar, E. Gabriela Chiorean, Anthony F. Shields, Deepti Behl, Paul Mehan, Rakesh Gaur, Tara Elisabeth Seery, Katherine A. Guthrie, Howard S. Höchster - Journal of Clinical Oncology 2019 被引用: 323

  6. Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma

    著者: Davendra Sohal, Mai Duong, Syed A. Ahmad, Namita Gandhi, Muhammad Shaalan Beg, Andrea Wang‐Gillam, James L. Wade, E. Gabriela Chiorean, Katherine A. Guthrie, Andrew M. Lowy, Philip A. Philip, Howard S. Höchster - JAMA Oncology 2021 被引用: 301

  7. Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

    著者: Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Heinz‐Josef Lenz, Anthony M. Magliocco, Dipen M. Maru, Yibing Yan, Richard B. Lanman, Ganiraju C. Manyam, David S. Hong, Alexey V. Sorokin, Chloé E. Atreya, Luis A. Díaz, Carmen J. Allegra, Kanwal Raghav, Stephen E Wang, Christopher H. Lieu, Shannon McDonough, Philip A. Philip, Howard S. Höchster - Journal of Clinical Oncology 2020 被引用: 391

  8. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

    著者: Arvind Dasari, Van K. Morris, Carmen J. Allegra, Chloé E. Atreya, Al B. Benson, Patrick M. Boland, Ki Yong Chung, Mehmet Sitki Copur, Ryan B. Corcoran, Dustin A. Deming, Andrea Dwyer, Maximilian Diehn, Cathy Eng, Thomas J. George, Marc J. Gollub, Rachel Goodwin, Stanley R. Hamilton, Jaclyn F. Hechtman, Howard S. Höchster, Theodore S. Hong, Federico Innocenti, Atif Iqbal, Samuel A. Jacobs, Hagen F. Kennecke, James J. Lee, Christopher H. Lieu, Heinz‐Josef Lenz, O. Wolf Lindwasser, Clara Montagut, Bruno C. Odisio, Fang‐Shu Ou, Laura Porter, Kanwal Raghav, Deborah Schrag, Aaron J. Scott, Qian Shi, John H. Strickler, Alan P. Venook, Rona Yaeger, Greg Yothers, Y. Nancy You, Jason A. Zell, Scott Kopetz - Nature Reviews Clinical Oncology 2020 被引用: 365

  9. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 被引用: 994

  10. NCCN Guidelines Insights: Colon Cancer, Version 2.2018

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Ignacio Garrido‐Laguna, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 被引用: 1,029

  11. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials

    著者: Carla Casulo, Jesse G. Dixon, Jennifer Le‐Rademacher, Eva Hoster, Howard S. Höchster, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Catherine Sebban, Emmanuel Gyan, Kenneth A. Foon, Tina Nielsen, Umberto Vitolo, Gilles Salles, Qian Shi, Christopher R. Flowers - Blood 2022 被引用: 163

  12. Open-label, Phase I Study of Nivolumab Combined with nab -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

    著者: Zev A. Wainberg, Howard S. Höchster, Edward Kim, Ben George, Aparna Kaylan, E. Gabriela Chiorean, David Waterhouse, Martin Guiterrez, Aparna R. Parikh, Rishi Jain, Daniel R. Carrizosa, Hatem Soliman, Thomas Lila, David J. Reiss, Daniel W. Pierce, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Peter J. O’Dwyer - Clinical Cancer Research 2020 被引用: 154

  13. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer

    著者: Jeffrey A. Meyerhardt, Qian Shi, Charles S. Fuchs, Jeffrey Meyer, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar, Katherine A. Guthrie, Félix Couture, Philip Kuebler, Johanna C. Bendell, Pankaj Kumar, DeQuincy Andrew Lewis, Benjamin Tan, Monica M. Bertagnolli, Axel Grothey, Howard S. Höchster, Richard M. Goldberg, Alan P. Venook, Charles D. Blanke, Eileen M. O’Reilly, Anthony F. Shields - JAMA 2021 被引用: 130

  14. Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

    著者: Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park, Hope E. Uronis, Keun-Wook Lee, Matthew Chau Hsien Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard S. Höchster, Sang Cheul Oh, Yeul Hong Kim, Kristen A. Marrone, Ronan J. Kelly, Rosalyn A. Juergens, Jong Gwang Kim, Johanna C. Bendell, Thierry Alcindor, Sun Jin Sym, Eun‐Kee Song, Cheng Ean Chee, Yee Chao, Sunnie S. Y. Kim, A. Craig Lockhart, Keith L. Knutson, Jennifer Yen, Aleksandra Franovic, Jeffrey L. Nordstrom, Daner Li, Jon M. Wigginton, Jan Davidson‐Moncada, Minori Koshiji Rosales, Yung‐Jue Bang - The Lancet Oncology 2020 被引用: 190

  15. Surgical Outcome Results From SWOG S1505

    著者: Syed A. Ahmad, Mai Duong, Davendra Sohal, Namita Gandhi, Muhammad Shaalan Beg, Andrea Wang‐Gillam, James L. Wade, E. Gabriela Chiorean, Katherine A. Guthrie, Andrew M. Lowy, Philip A. Philip, Howard S. Höchster - Annals of Surgery 2020 被引用: 233

  16. VEGF Inhibition and Renal Thrombotic Microangiopathy

    著者: Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska, Howard S. Höchster, Mark Haas, Joseph Weisstuch, C. A. Richardson, Jeffrey B. Kopp, M. Golam Kabir, Peter H. Backx, Hans-Peter Gerber, N. Ferrara, Laura Barisoni, Charles E. Alpers, Susan E. Quaggin - New England Journal of Medicine 2008 被引用: 1,494

  17. Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

    著者: Heinz‐Josef Lenz, Fang‐Shu Ou, Alan P. Venook, Howard S. Höchster, Donna Niedzwiecki, Richard M. Goldberg, Robert J. Mayer, Monica M. Bertagnolli, Charles D. Blanke, Tyler Zemla, Xueping Qu, Pratyaksha Wirapati, Sabine Tejpar, Federico Innocenti, Omar Kabbarah - Journal of Clinical Oncology 2019 被引用: 253

  18. SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

    著者: Rachna T. Shroff, Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind Javle, Carol Aghajanian, Benjamin Tan, P. Cheema, Anuj Patel, Renuka Iyer, Robin Kate Kelley, Jaykumar Thumar, Anthony B. El-Khoueiry, E. Gabriela Chiorean, Howard S. Höchster, Philip Agop Philip - Journal of Clinical Oncology 2023 被引用: 99

  19. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Lynette Cederquist, Emily Chan, Yi‐Jen Chen, Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom, Peter C. Enzinger, Alessandro Fichera, Jean L. Grem, Axel Grothey, Howard S. Höchster, Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard B. Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Christina Wu, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,371

  20. Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy

    著者: Vincent Chung, Shannon McDonough, Philip A. Philip, Dana B. Cardin, Andrea Wang‐Gillam, Laifong Hui, Mohamedtaki Abdulaziz Tejani, Tara Elisabeth Seery, Irene Dy, Tareq Al Baghdadi, Andrew Hendifar, L. Austin Doyle, Andrew M. Lowy, Katherine A. Guthrie, Charles D. Blanke, Howard S. Höchster - JAMA Oncology 2016 被引用: 177

  21. Cancer Stem Cells: The Promise and the Potential

    著者: Jaffer A. Ajani, Shumei Song, Howard S. Höchster, Ira B. Steinberg - Seminars in Oncology 2015 被引用: 318

  22. Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy

    著者: Michael A. Morse, Howard S. Höchster, Al B. Benson - The Oncologist 2019 被引用: 127

  23. Phase 2 results: Encorafenib (ENCO) and cetuximab (CETUX) with or without alpelisib (ALP) in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC).

    著者: Josep Tabernero, Robin M.J.M. van Geel, Tormod Kyrre Guren, Rona Yaeger, Anna Spreafico, Jason E. Faris, Takayuki Yoshino, Yasuhide Yamada, Tae Won Kim, Johanna C. Bendell, Martin Schüler, Heinz‐Josef Lenz, Ferry A.L.M. Eskens, Jayesh Desai, Howard S. Höchster, Emin Avşar, Tim Demuth, Victor Sandor, Elena Élez, Jan H.M. Schellens - Journal of Clinical Oncology 2016 被引用: 97

  24. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

    著者: Rachna T. Shroff, Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind Javle, Imane El Dika, Benjamin Tan, P. Cheema, Anuj Patel, Renuka Iyer, Robin Kate Kelley, Jaykumar Thumar, Anthony B. El-Khoueiry, Katherine A. Guthrie, E. Gabriela Chiorean, Howard S. Höchster, Philip A. Philip - Journal of Clinical Oncology 2024 被引用: 47